Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00141999 · ClinicalTrials.gov registry record
Response to Booster Doses of Hepatitis B Vaccine in Children and Adolescents
A clinical trial, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- 400
- Enrollment target
NCT00141999: Completed study, sponsored by Centers for Disease Control and Prevention.
NCT00141999 is a clinical trial that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00141999 has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the immune response to an additional (booster) dose of hepatitis B vaccine 5-14 years after a three dose series was given
Interventions
- BIOLOGICAL hepatitis B vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2001-05 |
| Est. Completion | 2008-03 |
What the finished NCT00141999 record still lists
NCT00141999 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which hepatitis B vaccine is the first listed.
NCT00141999 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00141999 about?
NCT00141999 is a clinical study titled "Response to Booster Doses of Hepatitis B Vaccine in Children and Adolescents". The purpose of this study is to determine the immune response to an additional (booster) dose of hepatitis B vaccine 5-14 years after a three dose series was given
What is the current status of trial NCT00141999?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2001-05. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00141999?
The interventions under investigation include: hepatitis B vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT00141999?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia